Dechra Relaunches Sedaxylan 20mg/ml Solution

2 years ago
867 views

Posted
24th January, 2023 11h52

Author
Dechra

Dechra is relaunching Sedaxylan 20 mg/ml solution for the sedation and premedication prior to general anaesthesia of dogs, cats, horses and cattle.

Sedaxylan 20 mg/ml contains the short acting alpha-2 agonist xylazine and is licensed for I/V administration. Providing flexible dosing options, it is also licensed for I/M administration in cattle and it is a popular premedication for use in cattle sedation and brief surgical procedures. It has zero milk withdrawal and short one day meat withdrawal and sedation occurs in cattle within two minutes I/V and five to 10 minutes I/M.

Sedaxylan 20 mg/ml joins Dechra’s Nerfasin vet 100 mg/ml solution in the company’s extensive anaesthesia and sedation range. Nerfasin vet also contains xylazine and is licensed for I/V administration for sedation and premedication prior to general anaesthesia in horses and cattle.

Alana McGlade, national sales manager at Dechra, comments: “Dechra offers a comprehensive range of anaesthesia and sedation products allowing vets to customise protocols to the individual animal. Sedaxylan 20mg/ml and Nerfasin vet 100 mg/ml solution provide vets with flexible and convenient dosing options.”

Both Sedaxylan 20 mg/ml and Nerfasin vet 100 mg/ml are available in 25ml vials.

For further information on Sedaxylan 20mg/ml or Nerfasin vet 100mg/ml, please contact your local Dechra territory sales manager or visit www.dechra.co.uk.

More from Dechra

• Dechra launches feline hyperthyroidism educational support
• ‘Bitesize’ canine Cushing’s syndrome webinar series now on Dechra Academy
• Dechra hosts strangles and equine disease management webinars
• Felimazole now available as an oral solution
• Dechra to host ‘bitesize’ canine Cushing’s syndrome CPD webinar series